Global Neurointerventional Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Embolic Protection Devices, Flow Diverters Devices, Intrasaccular Devices, Liquid Embolic, Balloons, and Stent Retrievers.

By Technique;

Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, and Flow Disruption.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn499962286 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Neurointerventional Devices Market (USD Million), 2021 - 2031

In the year 2024, the Global Neurointerventional Devices Market was valued at USD 2,894.86 million. The size of this market is expected to increase to USD 4,694.33 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.2%.

The Global Neurointerventional Devices Market is poised for significant growth, driven by the increasing prevalence of neurological disorders and advancements in medical technology. Neurointerventional devices are minimally invasive tools used to diagnose and treat vascular diseases of the central nervous system, including stroke, cerebral aneurysms, and arteriovenous malformations. These devices offer an alternative to traditional surgical procedures, providing patients with safer, less invasive options that often result in shorter recovery times and improved outcomes.

The rising incidence of stroke and other cerebrovascular diseases is a major factor propelling the demand for neurointerventional devices. As the global population ages, the burden of these conditions is expected to increase, further driving market growth. In addition, advancements in imaging technologies and the development of innovative devices have enhanced the precision and efficacy of neurointerventional procedures, making them more widely adopted by healthcare professionals.

Technological innovations, such as the development of next-generation stents, coils, and thrombectomy devices, are transforming the landscape of neurointerventional treatments. These advancements enable more effective management of complex neurovascular conditions, reducing the risk of complications and improving patient outcomes. The integration of artificial intelligence and robotics in neurointerventional procedures is opening new frontiers in the market, offering enhanced precision and control during interventions.

The market is experiencing dynamic growth fueled by technological advancements, increasing prevalence of neurological disorders, and a shift towards minimally invasive treatment options. As the market continues to evolve, it presents numerous opportunities for innovation and investment, ultimately aiming to enhance patient care and outcomes in the field of neurovascular interventions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Technique
    3. Market Snapshot, By Region
  4. Global Neurointerventional Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing neurological disorders
        2. Aging population
        3. Demand for minimally invasive procedures
        4. Awareness of stroke treatments
      2. Restraints
        1. Limited accessibility
        2. Regulatory hurdles
        3. Shortage of skilled professionals
        4. Risk of complications
      3. Opportunities
        1. Cost-effective devices
        2. AI and robotics integration
        3. Outpatient procedure growth
        4. Bioresorbable stents
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Neurointerventional Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Embolic Coils
      2. Carotid Stents
      3. Intracranial Stents
      4. Neurovascular Thrombectomy
      5. Embolic Protection Devices
      6. Flow Diverters Devices
      7. Intrasaccular Devices
      8. Liquid Embolic
      9. Balloons
      10. Stent Retrievers
    2. Global Neurointerventional Devices Market, By Technique, 2021 - 2031 (USD Million)
      1. Neurothrombectomy Procedure
      2. Cerebral Angiography
      3. Stenting
      4. Coiling Procedures
      5. Flow Disruption
    3. Global Neurointerventional Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Stryker Corporation
      2. Penumbra Inc.
      3. Covidien Public Limited
      4. Johnson & Johnson Private Limited
      5. Terumo Corporation
      6. Medtronic
      7. Boston Scientific
      8. MicroPort Scientific Corporation
      9. W. L. Gore & Associates, Inc.
      10. Abbott
      11. Philips Healthcare
      12. Siemens Healthineers
  7. Analyst Views
  8. Future Outlook of the Market